- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Steroid Refractory Graft Versus Host Disease
Total 1558 results
-
Astex Pharmaceuticals, Inc.TerminatedAcute Graft Versus Host DiseaseUnited States
-
Cynata Therapeutics LimitedCompletedGraft vs Host DiseaseAustralia, United Kingdom
-
MallinckrodtParexelCompletedChronic Graft Versus Host DiseaseUnited States, France, Germany, United Kingdom, Spain, Italy, Austria, Hungary
-
Ann & Robert H Lurie Children's Hospital of ChicagoDana-Farber Cancer Institute; Fred Hutchinson Cancer Center; University of MinnesotaCompletedGraft vs Host DiseaseUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Graft Versus Host DiseaseUnited States
-
ActelionTerminatedChronic Graft Versus Host DiseaseUnited States
-
Stanford UniversityCompletedGraft vs Host DiseaseUnited States
-
Karolinska InstitutetKarolinska University HospitalUnknownGraft vs Host DiseaseSweden
-
Guangdong Provincial People's HospitalSun Yat-sen UniversityUnknownGraft Versus Host DiseaseChina
-
Nantes University HospitalCompleted
-
University of RochesterTerminatedChronic Graft Versus Host DiseaseUnited States
-
Rabin Medical CenterUnknownGraft Versus Host DiseaseIsrael
-
University Health Network, TorontoHoffmann-La RocheTerminatedGraft Versus Host DiseaseCanada
-
HenogenWithdrawnAcute Graft Versus Host DiseaseNetherlands
-
Peking University People's HospitalRecruitingAcute Graft Versus Host DiseaseChina
-
AHS Cancer Control AlbertaRecruitingRelapse | Graft-versus-host-diseaseCanada
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)Belgium, Italy, Spain, Saudi Arabia, Turkey, United Kingdom, Germany, Greece, Canada, Austria, France, Israel, Netherlands, Sweden, Switzerland, Korea, Republic of, Bulgaria, Japan, Norway, Czechia, Russian Federation, Jordan, Hungary, Ind... and more
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedGraft Versus Host DiseaseUnited States
-
Andalusian Initiative for Advanced Therapies -...Andalusian Initiative for Advanced TherapiesCompletedAcute Graft Versus Host DiseaseSpain
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)United States
-
Janssen Pharmaceutical K.K.Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Graft Versus Host DiseaseUnited States
-
Indiana UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedGraft-Versus-Host DiseaseUnited States
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedGraft Versus Host DiseaseUnited States
-
Mehrdad Abedi, MDMillennium Pharmaceuticals, Inc.CompletedGraft Versus Host DiseaseUnited States
-
David MiklosNovartisCompletedGraft vs Host DiseaseUnited States
-
Medical College of WisconsinTerminatedAcute Graft Versus Host DiseaseUnited States
-
Pharmacyclics LLC.CompletedGraft Versus Host DiseaseUnited States
-
Gilead SciencesTerminatedChronic Graft Versus Host DiseaseSpain, Korea, Republic of, United States, Germany, Canada, France, United Kingdom
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedGraft Versus Host DiseaseUnited States
-
M.D. Anderson Cancer CenterMallinckrodtCompletedGraft Versus Host DiseaseUnited States
-
University Hospital, CaenUnknownChronic Graft Versus Host DiseaseFrance
-
National Eye Institute (NEI)The Emmes Company, LLCTerminated
-
University of Michigan Rogel Cancer CenterCompletedAcute Graft Versus Host DiseaseUnited States
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedChronic Graft Versus Host DiseaseUnited States
-
Karolinska InstitutetCompleted
-
Facet BiotechCompletedGraft vs Host DiseaseUnited States
-
University Hospital, Clermont-FerrandUnknownGraft Versus Host DiseaseFrance
-
Nanfang Hospital, Southern Medical UniversityShanghai iCELL Biotechnology Co., Ltd, Shanghai, ChinaNot yet recruitingAcute Graft Versus Host Disease
-
Biotech Pharmaceutical Co., Ltd.Recruiting
-
Peking University People's HospitalRecruiting
-
Mario ArpinatiEuropean CommissionRecruitingChronic Graft Versus Host DiseaseItaly
-
Everett MeyerNational Cancer Institute (NCI)WithdrawnGraft Versus Host DiseaseUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Graft Versus Host DiseaseUnited States, Australia, Austria, Canada, China, Croatia, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Singapore, Spain, Taiwan
-
Gruppo Italiano Trapianto di Midollo OsseoCompletedChronic Graft Versus Host DiseaseIsrael, Italy
-
John LevineBiogenCompletedAcute Graft Versus Host DiseaseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedChronic Graft Versus Host DiseaseUnited States
-
Mesoblast, Inc.CompletedGraft Versus Host DiseaseUnited States, Italy, Australia, Canada, Switzerland, United Kingdom
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedGraft Versus Host Disease (GVHD)United States